Vonacidan
Product Description
Alesraa Pharmaceutical Optime
-
EG -
2024On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
Alesraa Pharmaceutical Optime
-
EG
-
2024On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Alesraa Pharmaceutical Optime (3)
-
Product Allergicasone
Allergicasone combines 125 mg of azelastine, a potent antihistamine, and 50 mcg of fluticasone propionate, a powerful corticosteroid, to provide comprehensive relief from allergic rhinitis symptoms. The dual-action formula targets both histamine release and inflammation, effectively reducing nasal congesti... -
Product Dapablix/Dapablix Met
Dapablix contains dapagliflozin, an SGLT2 inhibitor that effectively reduces blood glucose levels by promoting renal glucose excretion. It is indicated for the management of type 2 diabetes mellitus, offering additional benefits such as weight reduction and cardiovascular risk mitigation.
Dapablix Met c... -
Product Larosuzet
Larosuzet integrates the strengths of ezetimibe, an intestinal cholesterol absorption inhibitor, and rosuvastatin, an HMG-CoA reductase inhibitor, to achieve optimal lipid control. This dual-action formula reduces LDL-C and total cholesterol levels more effectively than either agent alone. Larosuzet is sui...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance